Head & Neck / Thyroid / Salivary Gland Cancers
Contact Info
-
+123+456-7890 -
sarahlee@prohealth.com
Appointment Schedules
- Monday 09.00-12.00
- Wednesday 15.00-18.00
- Friday 09.00-12.00
Dr. Jochen H. Lorch
MD, MSc
Director Head & Neck and Thyroid Cancer Program, Northwestern University, Chicago, USA
Degrees
-
University of California, San Francisco.
Medical degree
-
University of California, Los Angeles (UCLA) Medical Center.
Completed residency training in psychiatry
-
University of California, Berkeley.
Master of Public Health degree
Experiences
-
Worked in community mental health clinics, private practice, and academic medical centers.
-
Expertise in the treatment of mood disorders, anxiety disorders, and psychotic disorders.
-
Special interest in womens mental health and perinatal psychiatry.
-
Experience managing complex cases that involve both mental health and medical issues.
Awards/Achievements
-
Fellow of the American Psychiatric Association (FAPA).
-
Recognized for research contributions with grants from the National Institute of Mental Health (NIMH) and the American Foundation for Suicide Prevention.
Dr Jochen Lorch is a world leader in head and neck cancers, salivary gland cancers and advanced thyroid cancers. He serves as the medical oncology director of the Head and Neck Cancer Program and the thyroid cancer program at Northwestern. Dr. Lorch earned his M.D. at the University of Regensburg, Germany. He completed his residency in Internal Medicine at the University of Pennsylvania/Presbyterian Medical Center and a fellowship in hematology/oncology at Northwestern. Dr. Lorch joined the Northwestern Medicine faculty in 2021. He is Professor of Medicine at the Northwestern Feinberg School of Medicine. Prior to joining Northwestern, Dr. Lorch served as director of clinical research at the division of head and neck oncology and the director of the thyroid center at Dana Farber Cancer Institute in Boston, MA, where he was also Associate Professor of Medicine at Harvard Medical School. Dr. Lorch's research interests include immunologic and targeted therapies of cancer and he has led multiple investigator initiated trials and translational research projects.
He heads the Thyroid Cancer Center and maintains an active clinical and translational research program at Dana Farber Cancer Insitiute.
